-3.25 Cylinder Now Stocked at Global Distribution Center
Richmond Hill, ON February 16, 2021—To expedite availability for eye care professionals (ECPs) and their patients, CooperVision, Inc. has expanded the range of Biofinity® XR toric contact lenses stocked at its global distribution center in West Henrietta, N.Y. The following parameter ranges are now available to ship next day to customers:
- Sphere: Plano to -6.00D (0.50 steps)
- Axis: 10° to 180° (10° steps)
- Cylinder: -2.75 and -3.25
Although Biofinity® XR toric remains a made-to-order product for many prescriptions, especially for patients with higher refractive errors, the expanded inventories will speed access as a growing number of ECPs adopt the lens.
CooperVision is also stocking trial lenses in the same parameters. Orders placed directly through CooperVision will ship the following business day.
“As the leading manufacturer of toric contact lenses, CooperVision has developed an unmatched portfolio of parameter options1,” said Michele Andrews, OD, Vice President of Professional & Government Affairs, Americas, CooperVision. “The levels of design, manufacturing, and supply chain innovations to deliver this range is complex, yet entirely worth our ongoing investments. Doing so allows ECPs the ability to fit even the most challenging patients3 with the proven toric lens that you can count on —and there is even more to come with further expansion of the range this year.”
Available in nearly 17,000 prescriptions, Biofinity® XR toric contact lenses enable eye care professionals to fit virtually all of their astigmatic patients. The unrivaled range of parameters also drives patient satisfaction, as the lenses provide patients with high amounts of astigmatism a combination of high oxygen permeability and all-day comfort.
“As eye care professionals increasingly prescribe Biofinity® XR toric, we are working to expedite delivery of some of the more common extended range prescriptions while saving optometry practices from having to store incredibly large fit sets,” said Dr. Andrews.
Biofinity® XR toric is a fully cast molded made to order lens that incorporates the same uniform horizontal ISO thickness and optimized ballast band design as Biofinity® toric, making it an easy-to-fit, stable toric lens with excellent visual acuity2. Its optimized, continuous surface ensures that the eyelid interacts with a smooth lens surface on every blink, resulting in a more comfortable wearing experience3.
Biofinity® XR toric lenses are available in sphere powers from +10.00D to -10.00D (0.50D steps after +/-6.00D), with cylinder powers from -2.75 to -5.75 (0.50 steps) and an axis of 5 degrees to 180 degrees in 5-degree steps.
For more information on Biofinity® XR toric, visit https://coopervision.ca/practitioner/our-products/biofinity-family/biofinity-xr-toric
# # #
1 CooperVision Data on File 2019. Based on Rx option combinations (sph, cyl, axis & ADD) manufactured, across all soft lenses in sphere, toric & multifocal (including made to order), in SiHy and hydrogel from 4 main manufacturers. Includes 1-Day, 2 weekly, and monthly disposable contact lenses. Cosmetic & Photochromatic contact lenses not included. Multiple base curve variants not included..
2CooperVision data on file 2019; prospective, double masked, bilateral, randomized, cross-over dispensing study n=39 habitual soft toric wearers.
3 Study compared the made-to-order (MTO) lens design of the Biofinity XR toric and stock Biofinity toric lens in the core range over six hours of wear.
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies (“Cooper”) is a global medical device company public traded on NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
McDougall Communications for CooperVision, Inc.
firstname.lastname@example.org or +1-585-434-2148